We participate in several multicenter clinical trials studying novel therapies for the treatment of Cystic Fibrosis and other forms of bronchiectasis. These therapies include anti-inflammatories, anti-infectives, and CFTR modulators in the form of Phase 1, 2, and 3 trials, both outpatient and inpatient.
We are also spearheading prospective clinical trials to understand the impact of natural hormone fluctuation, birth control, and pregnancy on markers of health in Cystic Fibrosis patients that correlate with our bench-related studies.
View Cystic Fibrosis Clinical Trials Online at:
Cystic Fibrosis and Bronchiectasis
Our adult Cystic Fibrosis Program is accredited by the Cystic Fibrosis Foundation. We serve over 250 adults with CF and have a multi-disciplinary team dedicated to the care of patients with CF.
Please contact our clinic at 214-645-0599 or visit our clinic website for further information.